| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2852054 | American Heart Journal | 2006 | 4 Pages |
Abstract
In patients with stable CAD, clopidogrel inhibits the release of sCD40l by platelets, which may contribute to the clinical benefit provided by this drug. This, however, does not translate in a reduction of subclinical inflammation, as measured by hs-CRP.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rabih R. MD, MSc, FACC, Roland MD, Antoine MD, Simon MD, Hazem MD, Pierre MD, Mirna PharmD, Elie MD,